Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026069. https://doi.org/10.4084/MJHID.2026.069.